Skip to main content
. 2018 Jul 6;9(52):29921–29933. doi: 10.18632/oncotarget.25699

Table 2. Multivariate analysis of prognostic factors in patients with cholangiocarcinoma.

Multivariate analysis (Overall Survival)
Variable Category Odds ratio p Confidence interval
Histologic Differentiation well or moderate/poor 2.266 0.040 1.038-4.946
T Status T2/T3 1.688 0.236 0.710-4.009
Overall Tumor Recurrence negative/positive 0.011 0.0001 0.001-0.093
Local Tumor Recurrence negative/positive 0.707 0.401 0.315-1.588
Multiple Tumor Nodules negative/positive 0.135 0.010 0.029-0.623
Tumor size negative/positive 0.006 0.001 0.000-0.137
TEMs in tumor negative/positive 2.423 0.040 1.042-5.633
miR-128 expression low/high 38.976 0.004 3.257-466.374
miR-126 expression low/high 0.322 0.013 0.131-0.789
Multivariate analysis (Recurrence-free Survival)
Variable Category Odds ratio p Confidence interval
Tumor Nodules solitary/multiple 0.301 0.001 0.149-0.606
Perineural Sheet Infiltration negative/positive 0.370 0.008 0.178-0.772
Histologic Differentiation well or moderate/poor 2.123 0.047 1.010-4.460
Lymph Node Involvement negative/positive 0.542 0.066 0.282-1.042
TEMs in tumor invasive front high/low 2.721 0.047 1.014-7.302

Following clinicopathological parameters were reported previously in the same cohort of patients: histologic differentiation, T status, overall and local tumor recurrence, multiple tumor nodules, tumor size, perineural sheet infiltration and lymph node involvement [37].